The role of Sativex in robotic rehabilitation in individuals with multiple sclerosis: Rationale, study design, and methodology

INTRODUCTION: Currently, none of the available multiple sclerosis (MS) disease-modifying medications has been shown to stop or reverse gait disability. Recently, the nabiximols has been tested for the treatment of spasticity and walking impairment in MS. Nabiximols (trade name Sativex) is an oromuco...

Descripción completa

Detalles Bibliográficos
Autores principales: Russo, Margherita, Dattola, Vincenzo, Logiudice, Anna Lisa, Ciurleo, Rosella, Sessa, Edoardo, De Luca, Rosaria, Bramanti, Placido, Bramanti, Alessia, Naro, Antonino, Calabrò, Rocco Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704890/
https://www.ncbi.nlm.nih.gov/pubmed/29145345
http://dx.doi.org/10.1097/MD.0000000000008826

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704890/
https://www.ncbi.nlm.nih.gov/pubmed/29145345
http://dx.doi.org/10.1097/MD.0000000000008826

Ejemplares similares